Home › Inflammatory Bowel Disease › Missouri › St. Louis
Inflammatory Bowel Disease clinical trials in St. Louis, MO
6 studies for Inflammatory Bowel Disease are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- and 1 more
Study of DISC-0974-201 in Participants With IBD and Anemia
RecruitingPhase 2
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2
- SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi away
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RecruitingPhase 3
- Washington University School of Medicine, St Louis
BOOM-IBD2 Pivotal Clinical Trial
Recruiting
- Gateway GI Research (Objective Health), St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Bridgeton · 15 mi away
Inflammatory Bowel Disease trials in other cities
- New York City, NY18 studies
- Boston, MA15 studies
- Miami, FL9 studies
- Seattle, WA9 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- Cincinnati, OH7 studies
- Washington, DC7 studies
- Houston, TX7 studies
- Orlando, FL7 studies
- Philadelphia, PA7 studies
- Baltimore, MD6 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer65 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer36 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.